These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 33232183)

  • 1. A comparative analysis of kratom exposure cases in Thailand and the United States from 2010-2017.
    Davidson C; Cao D; King T; Weiss ST; Wongvisavakorn S; Ratprasert N; Trakulsrichai S; Srisuma S
    Am J Drug Alcohol Abuse; 2021 Jan; 47(1):74-83. PubMed ID: 33232183
    [No Abstract]   [Full Text] [Related]  

  • 2. Kratom exposures reported to United States poison control centers: 2011-2017.
    Post S; Spiller HA; Chounthirath T; Smith GA
    Clin Toxicol (Phila); 2019 Oct; 57(10):847-854. PubMed ID: 30786220
    [No Abstract]   [Full Text] [Related]  

  • 3. Notes from the Field: Kratom (Mitragyna speciosa) Exposures Reported to Poison Centers - United States, 2010-2015.
    Anwar M; Law R; Schier J
    MMWR Morb Mortal Wkly Rep; 2016 Jul; 65(29):748-9. PubMed ID: 27466822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kratom exposures among older adults reported to U.S. poison centers, 2014-2019.
    Graves JM; Dilley JA; Terpak L; Brooks-Russell A; Whitehill JM; Klein TA; Liebelt E
    J Am Geriatr Soc; 2021 Aug; 69(8):2176-2184. PubMed ID: 34143890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kratom abuse in Ramathibodi Poison Center, Thailand: a five-year experience.
    Trakulsrichai S; Tongpo A; Sriapha C; Wongvisawakorn S; Rittilert P; Kaojarern S; Wananukul W
    J Psychoactive Drugs; 2013; 45(5):404-8. PubMed ID: 24592666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kratom exposures reported to Texas poison centers.
    Forrester MB
    J Addict Dis; 2013; 32(4):396-400. PubMed ID: 24325774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and description of kratom (Mitragyna speciosa) use in the United States: a cross-sectional study.
    Schimmel J; Amioka E; Rockhill K; Haynes CM; Black JC; Dart RC; Iwanicki JL
    Addiction; 2021 Jan; 116(1):176-181. PubMed ID: 32285981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of intentional-abuse venlafaxine exposures reported to poison control centers in the United States.
    Leonard JB; Klein-Schwartz W
    Am J Drug Alcohol Abuse; 2019; 45(4):421-426. PubMed ID: 30973750
    [No Abstract]   [Full Text] [Related]  

  • 9. The pharmacology and toxicology of kratom: from traditional herb to drug of abuse.
    Warner ML; Kaufman NC; Grundmann O
    Int J Legal Med; 2016 Jan; 130(1):127-38. PubMed ID: 26511390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2011 Annual report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 29th Annual Report.
    Bronstein AC; Spyker DA; Cantilena LR; Rumack BH; Dart RC
    Clin Toxicol (Phila); 2012 Dec; 50(10):911-1164. PubMed ID: 23272763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kratom (Mitragyna speciosa): User demographics, use patterns, and implications for the opioid epidemic.
    Garcia-Romeu A; Cox DJ; Smith KE; Dunn KE; Griffiths RR
    Drug Alcohol Depend; 2020 Mar; 208():107849. PubMed ID: 32029298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcomes after Kratom exposures: A poison center case series.
    Cumpston KL; Carter M; Wills BK
    Am J Emerg Med; 2018 Jan; 36(1):166-168. PubMed ID: 28751041
    [No Abstract]   [Full Text] [Related]  

  • 13. Kratom: Substance of Abuse or Therapeutic Plant?
    Gorelick DA
    Psychiatr Clin North Am; 2022 Sep; 45(3):415-430. PubMed ID: 36055730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacology of kratom: an emerging botanical agent with stimulant, analgesic and opioid-like effects.
    Prozialeck WC; Jivan JK; Andurkar SV
    J Am Osteopath Assoc; 2012 Dec; 112(12):792-9. PubMed ID: 23212430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Scheduling of Kratom and Selective Use of Data.
    Griffin OH; Webb ME
    J Psychoactive Drugs; 2018; 50(2):114-120. PubMed ID: 28937941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in intentional abuse and misuse ingestions in school-aged children and adolescents reported to US poison centers from 2000-2020.
    Hughes AR; Grusing S; Lin A; Hendrickson RG; Sheridan DC; Marshall R; Horowitz BZ
    Clin Toxicol (Phila); 2023 Jan; 61(1):64-71. PubMed ID: 36469528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and characteristics of self-reported kratom use in a representative US general population sample.
    Covvey JR; Vogel SM; Peckham AM; Evoy KE
    J Addict Dis; 2020; 38(4):506-513. PubMed ID: 32657217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abuse and Intentional Misuse of Promethazine Reported to US Poison Centers: 2002 to 2012.
    Tsay ME; Procopio G; Anderson BD; Klein-Schwartz W
    J Addict Med; 2015; 9(3):233-7. PubMed ID: 25822213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kratom exposures managed by the British Columbia poison centre, 2012-2019: a descriptive analysis.
    Reich N; Salvo G; Leong D; Wan V; Kosatsky T
    CMAJ Open; 2022; 10(3):E755-E761. PubMed ID: 35973710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2015 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 33rd Annual Report.
    Mowry JB; Spyker DA; Brooks DE; Zimmerman A; Schauben JL
    Clin Toxicol (Phila); 2016 Dec; 54(10):924-1109. PubMed ID: 28004588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.